DDX53 and neoplasm: In orthotopic transplantation models, NP-APC11, but not anti-PD1, effectively reduced tumor growth in CT26-shApc and AKP organoid models, with combination therapy yielding the most potent effects (Fig. 7o; Supplementary information, Fig. S9p).